Proteomics Intl Labs Ltd has released a press release.
Proteomics partnered consortium to receive $2 million
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- Appendix 4C - September 2017 Quarterly Report
- Proteomics receives R&D tax incentive
- PromarkerD predictive test results published - Diabetes Care
- US PromarkerD patent expanded to all kidney disease
- Appendix 4C - corrected
Later from Proteomics International Laboratories
- PromarkerD predictive diagnostic test to launch in Q1 2018
- Proteomics joins major health study to target lung disease
- Appendix 4C - December 2017 Quarterly Report
- PromarkerD diabetic kidney disease patent granted in Japan
- Strategic alliance and investment in CPR Pharma Services
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories